Cambridge-based AnthroTek Closes £950K Seed Funding

The company develops advanced synthetic human models for medical training and research, aiming to reduce reliance on cadavers and animals.

The funding will support product development, commercialization, and scaling to meet growing demand in healthcare and education.

The deal forms part of the £1.15M raised to date, valuing the company at £10.5M pre-money with an additional £550K tranche expected within the next 12 months.

Read Also - Hive Robotics raises €2M to enable robot collaboration across air, land, sea, and space

The newly secured capital will be directed toward expanding operations and advancing development efforts, supporting the company’s next stage of growth.

Founded in 2024 AnthroTek develops synthetic anatomy using advanced silicone composites that replicate human tissue for medical simulation, robotics, and entertainment. By blending AI, 3D technology and materials science, the company delivers ethical, high-fidelity anatomical solutions designed to meet global needs across healthcare, research and creative industries.

AnthroTek combines AI, 3D technology and advanced material science to pioneer hyper-realistic manufacturing of artificial skin, faces, and body parts. Using custom silicone modelling techniques, the company bridges medical, robotics, and SFX industries, delivering unmatched versatility and quality that outperforms single-domain players and sets new benchmarks across multiple sectors.

About AnthroTek

AnthroTek develops advanced silicone solutions for medical simulation, surgical training, robotics, and film. By combining cutting-edge materials with precision design, the company delivers hyper-realistic anatomical models that enhance learning, innovation and creativity across industries setting new standards for realism, functionality and ethical alternatives to traditional methods.